Terms: = Lymphoma AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Prognosis
5 results:
1. Suppression of super-enhancer-driven TAL1 expression by klf4 in T-cell acute lymphoblastic leukemia.
Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
[TBL] [Abstract] [Full Text] [Related]
2. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
Jakubikova J; Cholujova D; Beke G; Hideshima T; Klucar L; Leiba M; Jamroziak K; Richardson PG; Kastritis E; Dorfman DM; Anderson KC
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752202
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA‑9‑5p downregulates klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract] [Full Text] [Related]
4. Krüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma.
Li XY; Geng LY; Zhou XX; Wei N; Fang XS; Li Y; Wang X
Leuk Lymphoma; 2017 Oct; 58(10):2460-2469. PubMed ID: 28278702
[TBL] [Abstract] [Full Text] [Related]
5. Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
Chiew MY; Boo NY; Voon K; Cheong SK; Leong PP
Leuk Lymphoma; 2017 Jan; 58(1):162-170. PubMed ID: 27185517
[TBL] [Abstract] [Full Text] [Related]